T. Sasaki et al., STRUCTURE, FUNCTION AND TISSUE FORMS OF THE C-TERMINAL GLOBULAR DOMAIN OF COLLAGEN-XVIII CONTAINING THE ANGIOGENESIS INHIBITOR ENDOSTATIN, EMBO journal (Print), 17(15), 1998, pp. 4249-4256
The C-terminal domain NC1 of mouse collagen XVIII (38 kDa) and the sho
rter mouse and human endostatins (22 kDa) were prepared in recombinant
form from transfected mammalian cells. The NC1 domain aggregated non-
covalently into a globular trimer which was partially cleaved by endog
enous proteolysis into several monomers (25-32 kDa) related to endosta
tin. Endostatins were obtained in a highly soluble, monomeric form and
showed a single N-terminal sequence which, together with other data,
indicated a compact folding. Endostatins and NC1 showed a comparable b
inding activity for the microfibrillar fibulin-1 and fibulin-2, and fo
r heparin. Domain NC1, however, was a distinctly stronger ligand than
endostatin for sulfatides and the basement membrane proteins laminin-l
and perlecan. Immunological assays demonstrated endostatin epitopes o
n several tissue components (22-38 kDa) and in serum (120-300 ng/ml),
the latter representing the smaller variants. The data indicated that
the NC1 domain consists of an N-terminal association region (similar t
o 50 residues), a central protease-sensitive hinge region (similar to
70 residues) and a C-terminal stable endostatin domain (similar to 180
residues). They also demonstrated that proteolytic release of endosta
tin can occur through several pathways, which may lead to a switch fro
m a matrix-associated to a more soluble endocrine form.